ProfileGDS4718 / 1564876_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 58% 55% 58% 58% 59% 59% 56% 57% 53% 55% 54% 61% 58% 57% 57% 56% 60% 60% 54% 58% 59% 56% 54% 57% 56% 59% 59% 55% 61% 62% 58% 56% 56% 59% 58% 60% 57% 57% 58% 56% 61% 58% 59% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0782459
GSM549102patient 115, normal, homogenized [OPG study]5.990158
GSM549104patient 119, normal, homogenized [OPG study]5.8322255
GSM549108patient 138, normal, homogenized [OPG study]6.0085158
GSM549119patient 077, normal, homogenized [OPG study]5.9816958
GSM549133patient 032, cancer, homogenized [OPG study]6.0594459
GSM549139patient 042, cancer, homogenized [OPG study]6.0828159
GSM549099patient 107, normal, homogenized [OPG study]5.8627956
GSM549109patient 139, normal, homogenized [OPG study]5.9761357
GSM549110patient 046, normal, homogenized [OPG study]5.6771853
GSM549114patient 063, normal, homogenized [OPG study]5.7629255
GSM549122patient 082, normal, homogenized [OPG study]5.7775954
GSM549134patient 033, cancer, homogenized [OPG study]6.171961
GSM549136patient 036, cancer, homogenized [OPG study]5.9673658
GSM549140patient 044, cancer, homogenized [OPG study]5.9198457
GSM549111patient 047, normal, homogenized [OPG study]5.9530557
GSM549113patient 057, normal, homogenized [OPG study]5.824656
GSM549132patient 031, cancer, homogenized [OPG study]6.1213660
GSM549137patient 038, cancer, homogenized [OPG study]6.1614660
GSM549142patient 047, cancer, homogenized [OPG study]5.8778454
GSM549100patient 110, normal, homogenized [OPG study]5.9887558
GSM549107patient 135, normal, homogenized [OPG study]6.0394359
GSM549115patient 068, normal, homogenized [OPG study]5.8330156
GSM549116patient 072, normal, homogenized [OPG study]5.7406254
GSM549120patient 078, normal, homogenized [OPG study]5.9209657
GSM549131patient 030, cancer, homogenized [OPG study]5.8155656
GSM549118patient 074, normal, homogenized [OPG study]6.0592359
GSM549129patient 027, cancer, homogenized [OPG study]6.0679659
GSM549123patient 088, normal, homogenized [OPG study]5.7948955
GSM549124patient 006, cancer, homogenized [OPG study]6.2166761
GSM549126patient 015, cancer, homogenized [OPG study]6.283162
GSM549128patient 025, cancer, homogenized [OPG study]6.029958
GSM549103patient 117, normal, homogenized [OPG study]5.9070956
GSM549117patient 073, normal, homogenized [OPG study]5.8357156
GSM549138patient 041, cancer, homogenized [OPG study]6.0576359
GSM549141patient 045, cancer, homogenized [OPG study]5.9627558
GSM549130patient 028, cancer, homogenized [OPG study]6.0913260
GSM549101patient 111, normal, homogenized [OPG study]5.9612757
GSM549105patient 128, normal, homogenized [OPG study]5.9664557
GSM549106patient 134, normal, homogenized [OPG study]5.9328958
GSM549112patient 048, normal, homogenized [OPG study]5.8620356
GSM549125patient 011, cancer, homogenized [OPG study]6.1858361
GSM549127patient 024, cancer, homogenized [OPG study]6.0151758
GSM549135patient 035, cancer, homogenized [OPG study]6.0226359